PetVivo Animal Health

What PetVivo Animal Health does

PetVivo Animal Health (legal entity PetVivo Holdings, Inc.) is a publicly traded biomedical device and regenerative therapies company headquartered in Minneapolis, Minnesota, founded in 2014 and led by CEO John Lai. The company develops and commercializes proprietary veterinary medical devices and therapeutics for joint health management in companion animals (cats and dogs) and horses, targeting veterinary practices treating lameness, osteoarthritis, and reduced mobility. PetVivo operates through two wholly-owned subsidiaries: PetVivo Animal Health, Inc. for medical devices and PetVivo AI, Inc. for software offerings.

The company's product portfolio comprises three lines. (1) Spryng with OsteoCushion Technology, launched September 2021, is an intra-articular injectable consisting of sterilized extracellular matrix microparticles that integrate with joint tissue to restore proper joint mechanics and manage joint pain. (2) PrecisePRP, a leucoreduced allogeneic pooled freeze-dried platelet-rich plasma product, is described as the only PRP with FDA Risk Assessment Completed; canine (VMF 006-550) and equine (VMF 006-494) variants are FDA reviewed Lower Risk Animal Cells, Tissues, and Cell- and Tissue-Based Products (ACTPs), and the product is commercially available in the United States without requiring blood draw or centrifugation. (3) PetVivo.ai, launched November 2025, is an AI-powered SaaS platform using nine specialized AI agents to automate lead generation and client acquisition for veterinary practices; beta results cite 50–90% reductions in customer acquisition cost, $3 per qualified lead versus $15–45 traditional, 25:1 LTV/CAC, and 80–90% gross margins.

PetVivo generates revenue primarily through one-time sales of Spryng and PrecisePRP via a North American distribution network that includes Covetrus, MWI Animal Health, Patterson Veterinary, Vetcove, Midwest Veterinary Supply, Penn Veterinary Supply, Amatheon Animal Health, and Pharmsource, plus direct ordering from the company. The PetVivo.ai platform introduces a recurring subscription revenue stream. The company's stated strategic intent is to transition valuation multiples from medical device ratios (1–2x revenue) to AI SaaS ratios (15–30x revenue) through the PetVivo.ai launch. Marketing channels include industry conferences (e.g., ACVSMR Symposium), veterinary continuing education, a content blog, and virtual investor events; the operating geography is North America (USA), with select international distribution partners noted for PrecisePRP. No revenue, ARR, or headcount figures are disclosed in the available source material.

Name

PetVivo Animal Health

Legal name

PetVivo Holdings, Inc.

Website

https://petvivoanimalhealth.com

Company type

Public

Founded year

2014

Operating status

Operating

Headcount range

1–10 employees

Short description

PetVivo Animal Health (PetVivo Holdings, Inc.) is a publicly traded Minneapolis-based veterinary medical device and regenerative therapies company that develops and sells proprietary joint health products — Spryng, PrecisePRP, and the PetVivo.ai SaaS platform — to North American veterinary practices treating companion animals and horses.

Ownership category

akta.pro rank

Product category

Veterinary Medical Devices

SIC

Surgical & Medical Instruments & Apparatus (3841), Biological Products, (No Disgnostic Substances) (2836)

akta.pro primary industry

Companion Animal Therapeutics (Rx) (HLAMAEAA)

Keywords

• Veterinary regenerative medicine
• Animal joint health devices
• Platelet rich plasma veterinary
• Equine osteoarthritis treatment
• Veterinary medical devices

Headquarters

HQ city

Minneapolis

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Technology or R&D, Marketing or Sales, Personnel, Operations

Revenue model

1. Spryng with OsteoCushion Technology Sales: Sale of veterinary medical device for joint health management in cats, dogs, and horses. Distributed through multiple veterinary supply distributors and direct from PetVivo.
2. PrecisePRP Sales: Sale of off-the-shelf platelet-rich plasma product for veterinary use in dogs and horses. Available in species-specific formats (Canine and Equine).
3. PetVivo.ai SaaS Platform: AI-powered SaaS platform subscription for veterinary practices. Generates qualified leads at $3 per pet parent versus traditional $15-45. Expected to shift company valuation multiples from medical device ratios (1-2x revenue) to AI SaaS multiples (15-30x revenue).

Pricing tiers

Go-to-market motion2 records

Distribution channels7 records

Marketing channels4 records

Core offering

PetVivo Animal Health develops and commercializes proprietary regenerative medical devices and therapeutics for joint health management in companion animals and horses. Its product portfolio includes Spryng with OsteoCushion Technology, an intra-articular injectable device of sterilized extracellular matrix microparticles, and PrecisePRP, an off-the-shelf leucoreduced allogeneic freeze-dried platelet-rich plasma product. The company also operates PetVivo.ai, an AI-powered SaaS platform with nine specialized AI agents for veterinary practice lead generation and client acquisition.

Product overview

PetVivo Animal Health is a veterinary regenerative therapies company offering a portfolio of three distinct products: (1) Spryng with OsteoCushion Technology, an intra-articular injectable medical device launched September 2021 using sterilized extracellular matrix microparticles to manage joint health in horses, dogs, and cats; (2) PrecisePRP, a first-in-class off-the-shelf platelet-rich plasma product for dogs and horses that provides consistent dosing without requiring blood draw or centrifugation; and (3) PetVivo.ai, an AI-powered SaaS platform launched in November 2025 featuring nine specialized AI agents for veterinary practice lead generation and client acquisition. The company operates as a biomedical device and regenerative therapies firm focused on companion animals and equines, with products commercially available in the United States and through select international distribution partners.

Differentiator

Problem solved

Functional benefit

Brands

• Spryng with OsteoCushion Technology: Veterinarian-administered intra-articular injection for managing lameness and joint afflictions such as osteoarthritis in cats, dogs, and horses. Consists of sterilized extracellular matrix microparticles.
• PrecisePRP

Products and services

• Spryng with OsteoCushion Technology Veterinarian-administered intra-articular injectable medical device consisting of sterilized extracellular matrix microparticles that integrate with joint tissue to promote restoration of proper joint mechanics and aid in management of joint pain and osteoarthritis in cats, dogs, and horses.
• PrecisePRP First-in-class off-the-shelf leucoreduced allogeneic pooled freeze-dried platelet-rich plasma product for intra-articular administration in dogs and horses. Provides consistent dosing of 4 billion platelets per vial (500,000 platelets per μL) and does not require blood draw or centrifugation.
• PetVivo.ai AI-powered SaaS platform for veterinary practices featuring nine specialized AI agents that automate lead generation and client acquisition, generating qualified leads at $3 per pet parent versus traditional $15-45.

Quantifiable outcome

• 50-90% reduction in customer acquisition costs for veterinary practices using PetVivo.ai
• +4 more outcomes

Named customers1 record

Segments1 record

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature3 records

Partnerships

Nine partnerships are on record, tiered core and minor.

• CovetruscoreChannel Partner/ Reseller/ DistributorCovetrus serves as a major distribution channel for PetVivo products, making Spryng and PrecisePRP available through their North American veterinary supply platform to thousands of veterinary practices.
• MWI Animal HealthcoreChannel Partner/ Reseller/ DistributorMWI Animal Health distributes PetVivo products including Spryng and PrecisePRP to veterinary practices across their distribution network.
• Patterson VeterinarycoreChannel Partner/ Reseller/ DistributorPatterson Veterinary serves as a distributor partner for Spryng and PrecisePRP products, making them available to their veterinary practice customers.
• VetcovecoreChannel Partner/ Reseller/ DistributorVetcove marketplace offers Spryng products to veterinary practices through their e-commerce platform.
• Midwest Veterinary SupplycoreChannel Partner/ Reseller/ DistributorMidwest Veterinary Supply distributes PetVivo products including Spryng to veterinary practices.
• Penn Veterinary SupplycoreChannel Partner/ Reseller/ DistributorPenn Veterinary Supply serves as a distribution partner for Spryng products in the veterinary supply market.
• Amatheon Animal HealthminorChannel Partner/ Reseller/ DistributorAmatheon Animal Health distributes Spryng products as part of their veterinary pharmaceutical offerings.
• PharmsourceminorChannel Partner/ Reseller/ DistributorPharmsource distributes Spryng products as part of their animal health product portfolio.
• American College of Veterinary Sports Medicine and Rehabilitation (ACVSMR)minorGTM or Marketing PartnerPetVivo exhibited at the ACVSMR Symposium from March 26-29, 2026 in Lexington, Kentucky to showcase Spryng and PrecisePRP products to veterinary sports medicine and rehabilitation professionals.

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Elanco Animal Health: Elanco is a broad animal health incumbent with companion animal therapeutics and biologics that overlap with PetVivo's joint health and PRP offerings across the same veterinary channels.
• IDEXX Laboratories: IDEXX is a dominant veterinary diagnostics and software company whose practice management platforms compete with and could integrate AI features similar to PetVivo.ai within veterinary clinics.
• Zoetis: Zoetis is the largest global animal health company, offering PRP and orthopedic products that compete with PetVivo's portfolio while operating across pharmaceuticals, vaccines, and diagnostics at vastly greater scale.
• Heska (Mars Veterinary Health): Heska, now part of Mars Veterinary Health, offers in-clinic diagnostics, imaging, and software tools to veterinary practices — overlapping with PetVivo.ai's practice efficiency and patient acquisition positioning.
• Dechra Pharmaceuticals: Dechra (now part of the EQT-led Veloxis holding structure) is a specialty veterinary pharmaceuticals company whose orthopedic and pain management products compete with PetVivo's joint health devices and PRP.

Direct peers

• Gallant: Gallant is a direct-to-vet stem cell therapy company for dogs, addressing similar regenerative joint and orthopedic indications that PetVivo's Spryng targets in the companion animal market.
• Ardent Animal Health: Ardent Animal Health provides regenerative therapies including PRP and stem cell treatments for equine and companion animal joint conditions, directly competing with PetVivo's PrecisePRP and Spryng products.
• VetStem Biopharma: VetStem Biopharma is a direct peer offering regenerative stem cell therapy services for osteoarthritis and joint disease in companion animals and horses — the same clinical indication PetVivo targets with Spryng.

Emerging players

• PulseVet: PulseVet manufactures shock wave therapy devices for equine and companion animal orthopedic conditions, an alternative regenerative modality competing with PetVivo's intra-articular injectable approach.
• SentrX Animal Care: SentrX develops regenerative veterinary biologics for wound healing and ophthalmology, operating in the same regenerative medicine category as PetVivo but focused on different clinical indications.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/PetVivoAnimalHealth
• LinkedInlinkedin.com/company/petvivoanimalhealth

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about PetVivo Animal Health